Asset Dedication, LLC Vir Biotechnology, Inc. Transaction History

Asset Dedication, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 21, 2022	SELL	$30.97 - $54.03 $3,097 - $5,403	-100 Closed	0 $0
Q3 2021 Oct 18, 2021	BUY	$34.9 - $54.54 $3,490 - $5,454	100 New	100 $4,000
Q2 2021 Jul 21, 2021	SELL	$38.75 - $51.0 $4,185 - $5,508	-108 Closed	0 $0
Q1 2021 May 03, 2021	SELL	$26.34 - $83.07 $7,691 - $24,256	-292 Reduced 73.0%	108 $6,000
Q4 2020 Jan 28, 2021	BUY	$25.51 - $43.38 $10,204 - $17,352	400 New	400 $11,000

228

88.4M

571K

216K

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $1.28B
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of Asset Dedication, LLC, based on Form 13F filings with the SEC.

Stay updated on Asset Dedication, LLC with notifications on news.